© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
Oral Blarcamesine Shows Marked Reduction in Cognitive Decline in Early Alzheimer Disease: Phase 2b/3 Data
September 11, 2025
Once-daily blarcamesine was associated with minimal cognitive decline at 48 weeks, with changes comparable to those observed in prodromal aging.
Merck's 21-Valent Pneumococcal Vaccine Shows Positive Immune Response in At-Risk Children, Adolescents
September 11, 2025
Merck's CAPVAXIVE could cover approximately 78% of invasive pneumococcal disease cases in youth with chronic health conditions, vs other approved pneumococcal conjugate vaccines.
New Data Shows Risk of Major Depressive Disorder Spikes After a Medical Diagnosis: Daily Dose
September 11, 2025
Your daily dose of the clinical news you may have missed.
OX40 Antagonist Amlitelimab Meets All Primary and Secondary Endpoints in Phase 3 Atopic Dermatitis Trial
September 11, 2025
Sanofi's amlitelimab, dosed every 4 or 12 weeks, was superior to placebo in efficacy and skin clearance, with efficacy increasing throughout the treatment period.
How to Address Patient Hesitancy Around Cervical Cancer Screening, With Ada Stewart, MD
September 10, 2025
Ada Stewart, MD, shares strategies for primary care physicians to reduce patient anxiety and improve comfort during cervical cancer screening exams.
Approximately Half of People with Diabetes Worldwide Do Not Know They Have the Disease: GBD Analysis
September 10, 2025
Nor does receiving a diabetes diagnosis guarantee optimal management as just one-fifth of people treated for the disease reached glycemic control in 2023.
The IPF Pipeline is Set to Deliver: The 3 Top Contenders
September 10, 2025
Nerandomilast, with a PDUFA date of Q4 2025, leads the potential breakthrough therapies, with inhaled treprostinil and admilparant advancing quickly behind.
New Cancerguard Blood Test for Multicancer Early Detection Now Available in the US
September 10, 2025
Exact Sciences launches Cancerguard, a groundbreaking blood test for early cancer detection, aiming to transform cancer screening and save lives.
Prior CT Scans Found Linked With Higher Risk of Pregnancy Loss and Birth Defects
September 10, 2025
Although overall risk was just slightly elevated, study authors recommend alternative imaging methods when appropriate for women of childbearing age.
First Generic GLP-1 RA Approved for Weight Management in the US: Daily Dose
September 10, 2025
Your daily dose of the clinical news you may have missed.